In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 13 June 2019. Simon Richards.

Executive Summary

At this month's Asian Medtech Associations' Regulatory Networking event, concerns were raised that the IVD industry may be facing a false sense of security given that the EU IVDR deadline is two years later than that for the MDR. See what Simon Richards, board member and former chair of the British In Vitro Diagnostics Association (BIVDA), said about it here.

“We will see a reduction generally across the industry in products that are supplied, going forward.” Simon Richards, board member, British In Vitro Diagnostics Association

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts